Insulet
PODD
#1017
Rank
A$29.56 B
Marketcap
$421.41
Share price
-0.22%
Change (1 day)
63.83%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.46 Billion

According to Insulet's latest financial reports the company's current earnings are A$1.87 Billion. In 2023 the company made an earning of A$0.38 Billion, an increase over its 2022 earnings that were of A$66.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.46 B20.06%
2023 A$0.38 B481.9%
2022 A$66.02 M-45.24%
2021 A$0.12 B43.35%
2020 A$84.09 M18.51%
2019 A$70.96 M41.16%
2018 A$50.27 M-711.95%
2017 -A$8.22 Million-56.85%
2016 -A$19.05 Million-79.31%
2015 -A$92.05 Million63.85%
2014 -A$56.18 Million31.04%
2013 -A$42.87 Million-21.96%
2012 -A$54.94 Million
2010 -A$52.4 Million-42.38%
2009 -A$90.93 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$82.48 Million209.75%
2006 -A$26.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.24 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.21 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.16 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.17 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.38 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.64 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$15.54 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA